rs137948118
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000374811.8(LAS1L):c.940G>A(p.Val314Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000126 in 1,193,226 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000374811.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAS1L | NM_031206.7 | c.940G>A | p.Val314Ile | missense_variant | 7/14 | ENST00000374811.8 | NP_112483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAS1L | ENST00000374811.8 | c.940G>A | p.Val314Ile | missense_variant | 7/14 | 1 | NM_031206.7 | ENSP00000363944 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000622 AC: 7AN: 112571Hom.: 0 Cov.: 24 AF XY: 0.0000576 AC XY: 2AN XY: 34723
GnomAD3 exomes AF: 0.00000598 AC: 1AN: 167294Hom.: 0 AF XY: 0.0000184 AC XY: 1AN XY: 54472
GnomAD4 exome AF: 0.00000740 AC: 8AN: 1080601Hom.: 0 Cov.: 27 AF XY: 0.0000144 AC XY: 5AN XY: 348363
GnomAD4 genome AF: 0.0000622 AC: 7AN: 112625Hom.: 0 Cov.: 24 AF XY: 0.0000575 AC XY: 2AN XY: 34787
ClinVar
Submissions by phenotype
Wilson-Turner syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2017 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with LAS1L-related disease. This variant is present in population databases (rs137948118, ExAC 0.02%). This sequence change replaces valine with isoleucine at codon 314 of the LAS1L protein (p.Val314Ile). The valine residue is weakly conserved and there is a small physicochemical difference between valine and isoleucine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at